TRYNGOLZA® is a pioneering treatment developed by Ionis Pharmaceuticals specifically designed for adults suffering from severe hypertriglyceridemia (sHTG) and familial chylomicronemia syndrome (FCS). This FDA-approved medication, known scientifically as olezarsen, works effectively to lower triglyceride levels in the bloodstream, reducing the risk of acute pancreatitis associated with these conditions.

TRYNGOLZA® is intended to be used in conjunction with dietary modifications to achieve optimal results. It is essential for patients to consult their healthcare providers to determine the suitability of TRYNGOLZA® for their specific medical circumstances. While the treatment shows significant promise, users should be aware of potential side effects, including allergic reactions and changes in liver enzyme levels, necessitating ongoing medical supervision.

For those struggling with managing very high triglycerides, TRYNGOLZA® offers a targeted solution, bringing hope to many seeking to control their condition effectively. Stay informed by discussing your treatment options with your healthcare professional.